Bayer HealthCare / Homepage

Search
Font size
- 1 2 3 + Font size

click to adjust

Page tools
Bayer HealthCare worldwide
Financial Report
Clinical trials
Press portal

World Health Summit 2009

News


01/25/10, Hemophillia Bayer to Discontinue Phase II Clinical Trial for Long-Acting Recombinant Factor VIII Following Interim Analysis Study will not be able to meet primary endpoint / Bayer remains committed to developing its long-acting recombinant factor VIII compounds; alternative candidates in development more


01/12/10, Diagnostic Imaging Bayer Schering Pharma receives green light from European authorities to use Gadovist® 1.0 in children Berlin, January 12, 2010 – Bayer Schering Pharma AG successfully completed the procedure for securing approval to use the contrast medium Gadovist® 1.0 in children aged seven and above in Euro... more

Aspirin Tablet

Eleven things you (perhaps) didn’t know about Aspirin

March 6 is the 110th anniversary of the day on which Bayer registered the analgesic Aspirin containing the active ingredient acetylsalicylic acid under number 36433 in the list of trade names at the Imperial Patent Office in Berlin – the first step in a triumphant march that has remained unparalleled in medical history ever since.

No other drug product enjoys such widespread use – and there are few others that can look back on such a long history. Yet no matter how familiar Aspirin may seem, there may well be a few things that you (perhaps) didn’t know about the drug of the century. more

http://www.bayerhealthcare.com/scripts/pages/en/index.php Copyright © Bayer HealthCare